Royal Bank of Canada
MSLI

Royal Bank of Canada’s Merus Labs International Inc. MSLI Stock Holding History

Royal Bank of Canada’s Portfolio MSLI Stock Details MSLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,865
Closed -$17K – 7322
2017
Q2 		$17K Sell
13,865
-546,193
-98% -$567K ﹤0.01% 5614
2017
Q1 		$521K Sell
560,058
-24,128
-4% -$20.8K ﹤0.01% 3607
2016
Q4 		$509K Buy
584,186
+193,831
+50% +$178K ﹤0.01% 3727
2016
Q3 		$402K Buy
390,355
+17,070
+5% +$19.3K ﹤0.01% 3895
2016
Q2 		$477K Buy
373,285
+236,631
+173% +$331K ﹤0.01% 3748
2016
Q1 		$200K Buy
136,654
+115,349
+541% +$160K ﹤0.01% 4372
2015
Q4 		$34K Sell
21,305
-1,635
-7% -$2.23K ﹤0.01% 5505
2015
Q3 		$29K Buy
22,940
+11,640
+103% +$23.1K ﹤0.01% 5420
2015
Q2 		$26K Buy
11,300
+3,800
+51% +$9.22K ﹤0.01% 5582
2015
Q1 		$16K Buy
+7,500
New +$13.8K ﹤0.01% 5436

Royal Bank of Canada's MSLI Position: Q3 2017 in Review

Royal Bank of Canada sold out of Merus Labs International Inc. (MSLI) in Q3 2017, closing a stake of 13,865 shares — an estimated $17K sold.

Royal Bank of Canada first reported a position in MSLI in Q1 2015 and held it in 10 quarters. The position peaked at $521K in Q1 2017. 0 funds tracked by Wall St. Rank hold MSLI as of Q3 2017.

  • Royal Bank of Canada reported no remaining Merus Labs International Inc. position as of Q3 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 13,865 Merus Labs International Inc. shares in Q3 2017, an estimated $17K.
  • Royal Bank of Canada first reported a position in Merus Labs International Inc. in Q1 2015 and held it in 10 quarters.
  • Royal Bank of Canada's Merus Labs International Inc. position peaked at $521K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2017.

Based on Royal Bank of Canada's 13F filing for Q3 2017, filed 14 Nov 2017.